0001104659-23-074561.txt : 20230626
0001104659-23-074561.hdr.sgml : 20230626
20230626084528
ACCESSION NUMBER: 0001104659-23-074561
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230623
FILED AS OF DATE: 20230626
DATE AS OF CHANGE: 20230626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mosseri Marlio Charles
CENTRAL INDEX KEY: 0001806384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41264
FILM NUMBER: 231039514
MAIL ADDRESS:
STREET 1: 27 RIPPLEVALE GROVE
CITY: LONDON
STATE: X0
ZIP: N1 1HS
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvectis Pharma, Inc.
CENTRAL INDEX KEY: 0001875558
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862405608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
BUSINESS PHONE: 360-837-7232
MAIL ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
4
1
tm2319640-1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-23
0
0001875558
Nuvectis Pharma, Inc.
NVCT
0001806384
Mosseri Marlio Charles
27 RIPPLEVALE GROVE
LONDON
N1
1HS
LIBYAN ARAB JAMAHIRIYA
0
0
1
0
0
Common Stock
2023-06-23
4
P
0
73175
17.43
A
2511265
D
Reflects the weighted average purchase price. The range of prices for the shares purchased was $16.9149 to $17.7559. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
/s/ Charles Mosseri-Marlio
2023-06-26